SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
1-Year Return
0.41%
This Quarter Return
+12.43%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$565M
AUM Growth
-$87.1M
(-13%)
Cap. Flow
-$125M
Cap. Flow
% of AUM
-22.21%
Top 10 Holdings %
Top 10 Hldgs %
37.05%
Holding
162
New
40
Increased
21
Reduced
46
Closed
39
Top Buys
| 1 |
Gilead Sciences
GILD
|
$17.9M |
| 2 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
$15.9M |
| 3 |
Biogen
BIIB
|
$13.6M |
| 4 |
Bristol-Myers Squibb
BMY
|
$8.86M |
| 5 |
BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
|
$6.96M |
Top Sells
| 1 |
Merck
MRK
|
$24.8M |
| 2 |
AbbVie
ABBV
|
$23.3M |
| 3 |
AGN
ALLERGAN INC
AGN
|
$23M |
| 4 |
Johnson & Johnson
JNJ
|
$22.1M |
| 5 |
Teva Pharmaceuticals
TEVA
|
$14.4M |
Sector Composition
| 1 | Healthcare | 65.51% |
| 2 | Technology | 5.3% |
| 3 | Industrials | 3.85% |
| 4 | Energy | 1.97% |
| 5 | Consumer Discretionary | 1.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCOM
76
DELISTED
B Communications Ltd
BCOM
| $2.42M | 0.41% |
134,174
-187,257
| -58% | -$3.37M |
|
|
CEMP
77
DELISTED
Cempra, Inc.
CEMP
| $2.35M | 0.4% |
+100,000
| New | +$2.35M |
|
78
Eledon Pharmaceuticals
ELDN
$156M
| $2.27M | 0.39% |
950
-470
| -33% | -$1.12M |
|
79
Larimar Therapeutics
LRMR
$331M
| $2.22M | 0.38% |
6,008
-2,084
| -26% | -$771K |
|
80
CSX Corp
CSX
$60.9B
| $2.16M | 0.37% |
178,944
-240,081
| -57% | -$2.9M |
|
81
Ormat Technologies
ORA
$5.54B
| $2.13M | 0.36% |
309,000
+289,111
| +1,454% | +$1.99M |
|
82
Immunic
IMUX
$76M
| $2.04M | 0.35% |
+2,048
| New | +$2.04M |
|
83
Enanta Pharmaceuticals
ENTA
$190M
| $2.03M | 0.35% |
+40,000
| New | +$2.03M |
|
84
Nice
NICE
$8.56B
| $2.01M | 0.34% |
39,652
-24,890
| -39% | -$1.26M |
|
|
CNCE
85
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $2M | 0.34% |
150,000
+127,300
| +561% | +$1.7M |
|
|
PTLA
86
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $1.98M | 0.34% |
+70,000
| New | +$1.98M |
|
87
Ellomay Capital Ltd
ELLO
$235M
| $1.98M | 0.34% |
203,778
+12,576
| +7% | +$122K |
|
88
Starbucks
SBUX
$98.9B
| $1.97M | 0.34% |
+48,000
| New | +$1.97M |
|
|
LJPC
89
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $1.85M | 0.32% |
100,230
-123,100
| -55% | -$2.27M |
|
|
CTIC
90
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $1.77M | 0.3% |
+75,000
| New | +$1.77M |
|
|
ICPT
91
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.56M | 0.27% |
10,000
-4,565
| -31% | -$712K |
|
|
CKP
92
DELISTED
CHECKPOINT SYSTEMS INC
CKP
| $1.55M | 0.26% |
+19,688
| New | +$1.55M |
|
|
ACHN
93
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $1.54M | 0.26% |
+125,538
| New | +$1.54M |
|
94
Amgen
AMGN
$151B
| $1.36M | 0.23% |
8,550
-40,000
| -82% | -$6.37M |
|
95
Prothena Corp
PRTA
$442M
| $1.3M | 0.22% |
62,632
+32,725
| +109% | +$679K |
|
96
WIX.com
WIX
$8.19B
| $1.24M | 0.21% |
+59,108
| New | +$1.24M |
|
|
RXDX
97
DELISTED
Ignyta, Inc.
RXDX
| $1.23M | 0.21% |
179,055
-20,000
| -10% | -$137K |
|
|
GNVC
98
DELISTED
GenVec, Inc.
GNVC
| $1.2M | 0.2% |
55,833
| – | – |
|
|
GNMX
99
DELISTED
Aevi Genomic Medicine, Inc.
GNMX
| $1.14M | 0.19% |
+225,000
| New | +$1.14M |
|
100
Neurocrine Biosciences
NBIX
$13.9B
| $1.12M | 0.19% |
+50,000
| New | +$1.12M |
|